Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $262.62 Million |
|---|---|
| Enterprise Value | $268.37 Million |
| Earnings per Share | $-3.78 |
| Beta | -0.28 |
| Outstanding Shares | 14,351,000 |
| P/E Ratio | -6.41 |
|---|---|
| PEG | 14.39 |
| Price to Sales | 1.83 |
| Price to Book Ratio | -18.3 |
| Enterprise Value to Revenue | 1.78 |
| Enterprise Value to EBIT | -5.67 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | -7.7 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America...